US Patent Issued to TEMPUS AI on June 23 for "Platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer" (California, Illinois Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,663,414, issued on June 23, was assigned to TEMPUS AI INC. (Chicago).

"Platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer" was invented by Chi-Sing Ho (Redwood City, Calif.), Madhavi Kannan (Bloomington, Ill.), Sonal Khare (Chicago), Brian Larsen (Chicago), Brandon Mapes (Chicago), Ameen Salahudeen (Oak Park, Ill.) and Jagadish Venkataraman (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for characterizing cancer organoid response to an immune cell based therapy, includes providing a panel of different combinations of cancer organoid cells and immune cells to...